HER2 immunohistochemical evaluation in lymph node metastases
What is it about?
We have reported the discordance in immunoexpression of HER2 in primary breast carcinoma and synchronous axillary lymph node metastases.
Why is it important?
The positivity in lymph node metastases may allow the possibility of target therapy.
The following have contributed to this page: Professor Giovanni Tuccari, Dr Rosario Caltabiano, and Professor daniela cabibi
In partnership with: